-
1
-
-
70049083997
-
Basal cell carcinomas: molecular abnormalities and molecularly targeted therapies
-
Dummer R, Karpova MB, Barysch MJ Basal cell carcinomas: molecular abnormalities and molecularly targeted therapies. Expert Rev Dermatol 2009, 4:335-369.
-
(2009)
Expert Rev Dermatol
, vol.4
, pp. 335-369
-
-
Dummer, R.1
Karpova, M.B.2
Barysch, M.J.3
-
2
-
-
79955517437
-
Mommy-where do tumors come from?
-
Epstein EH Mommy-where do tumors come from?. J Clin Invest 2011, 121:1681-1683.
-
(2011)
J Clin Invest
, vol.121
, pp. 1681-1683
-
-
Epstein, E.H.1
-
3
-
-
78149299835
-
Non-melanoma skin cancers in New Zealand-a neglected problem
-
Brougham ND, Dennett ER, Tan ST Non-melanoma skin cancers in New Zealand-a neglected problem. N Z Med J 2010, 123:59-65.
-
(2010)
N Z Med J
, vol.123
, pp. 59-65
-
-
Brougham, N.D.1
Dennett, E.R.2
Tan, S.T.3
-
4
-
-
53749103876
-
A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up
-
Szeimies RM, Ibbotson S, Murrell DF, et al. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol 2008, 22:1302-1311.
-
(2008)
J Eur Acad Dermatol Venereol
, vol.22
, pp. 1302-1311
-
-
Szeimies, R.M.1
Ibbotson, S.2
Murrell, D.F.3
-
5
-
-
57749201993
-
Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: conclusion of a 5-year long-term follow-up study in Europe
-
Gollnick H, Barona CG, Frank RG, et al. Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: conclusion of a 5-year long-term follow-up study in Europe. Eur J Dermatol 2008, 18:677-682.
-
(2008)
Eur J Dermatol
, vol.18
, pp. 677-682
-
-
Gollnick, H.1
Barona, C.G.2
Frank, R.G.3
-
6
-
-
84878346748
-
Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial
-
published online May 15.
-
Arits A, Mosterd K, Essers B, et al. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Lancet Oncol 2013, published online May 15. http://dx.doi.org/10.1016/S1470-2045(13)70143-8.
-
(2013)
Lancet Oncol
-
-
Arits, A.1
Mosterd, K.2
Essers, B.3
-
7
-
-
45749085217
-
Guidelines for the management of basal cell carcinoma
-
Telfer NR, Colver GB, Morton CA Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008, 159:35-48.
-
(2008)
Br J Dermatol
, vol.159
, pp. 35-48
-
-
Telfer, N.R.1
Colver, G.B.2
Morton, C.A.3
-
8
-
-
1542317550
-
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
-
Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303:1529-1531.
-
(2004)
Science
, vol.303
, pp. 1529-1531
-
-
Diebold, S.S.1
Kaisho, T.2
Hemmi, H.3
Akira, S.4
Reis e Sousa, C.5
-
9
-
-
23244432171
-
Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment
-
Urosevic M, Dummer R, Conrad C, et al. Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment. J Natl Cancer Inst 2005, 97:1143-1153.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 1143-1153
-
-
Urosevic, M.1
Dummer, R.2
Conrad, C.3
-
10
-
-
84875878203
-
Aldara activates TLR7-independent immune defence
-
Walter A, Schafer M, Cecconi V, et al. Aldara activates TLR7-independent immune defence. Nat Commun 2013, 4:1560.
-
(2013)
Nat Commun
, vol.4
, pp. 1560
-
-
Walter, A.1
Schafer, M.2
Cecconi, V.3
|